Benralizumab Shows Benefits for Hypereosinophilic Syndrome



Targeted therapy delivered via injection delays flares in a phase 3 study.
Medscape Medical News



Source link : https://www.medscape.com/viewarticle/benralizumab-shows-benefits-hypereosinophilic-syndrome-2025a1000vbu?src=rss

Author :

Publish date : 2025-11-12 11:37:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version